Providence Medical Technology, Inc.
PrivateLast Round
VC Round
Sep 20, 2018
Total Funding Raised
$23.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Providence Medical Technology, Inc. is a medical devices & equipment company that develops and sells innovative surgical equipment and implants for cervical and lumbar spine fusion surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Providence Medical Technology, Inc. Comparables
Compare Providence Medical Technology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xenco Medical | 89% | |
| Neo Medical SA | 86% | |
| Wenzel Spine, Inc. | 84% |
Providence Medical Technology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 20, 2018 | ||||
| Debt | May 10, 2017 | ||||
| VC Round | Dec 19, 2016 | ||||
| VC Round | Aug 26, 2015 | ||||
| Debt | Sep 29, 2014 | ||||
Debt | Jul 1, 2014 |
Key People
Founding team and executive leadership
Providence Medical Technology, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Series C |
| BMO Global Asset Management | VC Round |
| Aphelion Capital | Series C, VC Round |
| Revelation Partners | VC Round |
| Bridge Bank | Debt |
| Medvest Capital | VC Round, Series C |
| Silicon Valley Bank | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 49% MoM.
- Feb 4, 2026
Jim Hens appointed as new Chief Commercial Officer.
Recent news
Latest coverage and updates
- hiresAug 7, 2026
Providence Medical Technology, Inc. hired Lane Major as President & Chief Executive Officer on Aug 6th '26.
- is_developingAug 6, 2026
Providence Medical Technology, Inc. is developing technologies for supplemental posterior fixation and fusion procedures.
Providence Medical Technology, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Providence Medical Technology, Inc.'s valuation, stock price, and market status.
Is Providence Medical Technology, Inc. a public or private company?
Providence Medical Technology, Inc. is a private company.
What is the current stock price of Providence Medical Technology, Inc.?
Providence Medical Technology, Inc. is a private company, so its shares have no public market price. Caplight tracks Providence Medical Technology, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Providence Medical Technology, Inc. worth (valuation)?
Valuation information for Providence Medical Technology, Inc. is not publicly available.
Can I buy Providence Medical Technology, Inc. stock?
Providence Medical Technology, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Providence Medical Technology, Inc.'s last funding round?
Providence Medical Technology, Inc.'s most recent funding round was VC Round on September 20, 2018.
Who are the main investors in Providence Medical Technology, Inc.?
Key investors in Providence Medical Technology, Inc. include Revelation Partners, Medvest Capital, MVM Life Science Partners LLP.
Will Providence Medical Technology, Inc. IPO soon?
No public IPO plans have been announced for Providence Medical Technology, Inc..
How can I track Providence Medical Technology, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Providence Medical Technology, Inc.'s shares on secondary markets.